1: Jochem J, Zwirska-Korczala K, Rybus-Kalinowska B, Jagodzińska J, Korzonek-
Szlacheta I. Influence of SKF 91488, histamine N-methyltransferase inhibitor, on
the central cardiovascular regulation during controlled, stepwise hemorrhagic
hypotension in rats. Pol J Pharmacol. 2002 May-Jun;54(3):237-44. PMID: 12398155.
2: Malmberg-Aiello P, Lamberti C, Ipponi A, Hänninen J, Ghelardini C, Bartolini
A. Effects of two histamine-N-methyltransferase inhibitors, SKF 91488 and BW 301
U, in rodent antinociception. Naunyn Schmiedebergs Arch Pharmacol. 1997
Mar;355(3):354-60. doi: 10.1007/pl00004954. PMID: 9089666.
3: Jochem J. Endogenous central histamine-induced reversal of critical
haemorrhagic hypotension in rats--studies with histamine N-methyltransferase
inhibitor SKF 91488. Inflamm Res. 2002 Nov;51(11):551-6. doi:
10.1007/pl00012426. PMID: 12540019.
4: Klein MC, Gertner SB. Evidence for a role of endogenous histamine in central
cardiovascular regulation: inhibition of histamine-N-methyltransferase by SKF
91488. J Pharmacol Exp Ther. 1981 Feb;216(2):315-20. PMID: 6450831.
5: Nakazawa H, Sekizawa K, Morikawa M, Yamauchi K, Satoh M, Maeyama K, Watanabe
T, Sasaki H. Viral respiratory infection causes airway hyperresponsiveness and
decreases histamine N-methyltransferase activity in guinea pigs. Am J Respir
Crit Care Med. 1994 May;149(5):1180-5. doi: 10.1164/ajrccm.149.5.8173757. PMID:
8173757.
